Circio Holding ASA (CRNA) NOK0.6
Sell:0.79 NOKBuy:0.84 NOK
0.12 NOK
(17.22%)
- This stock can be held in a
Stocks and Shares ISA0.12 NOK
(17.22%)0.12 NOK
(17.22%)Company Information
About this company
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Key people
Key facts
- EPICCRNA
- LocationNorway
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINNO0013033795
- Market capNOK 58.14m
- Employees10
- Shares in issue70.15m
- ExchangeOslo Stock Exchange
- IndexOSL All-share Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.